Samsara BioCapital, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share (PVLA)

Filing Manager
Samsara BioCapital, L.P.
Reporting Manager
Samsara BioCapital, L.P.
Security
Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
PVLA
Shares outstanding
11M shares
Disclosed Ownership
340K shares
Ownership
3.1%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 17:26:47 UTC
Date of event
30 Jun 2025
Previous filing
20 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samsara BioCapital, L.P. 3.1% 340K 0 340K /s/ Srinivas Akkaraju By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member
Samsara BioCapital GP, LLC 3.1% 340K 0 340K /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member
Srinivas Akkaraju 3.1% 340K 0 340K /s/ Srinivas Akkaraju Srinivas Akkaraju